CETP rs3764261: What Your Genotype Means
The rs3764261 variant is a well-studied single nucleotide polymorphism located in the regulatory region of the cholesteryl ester transfer protein (CETP) gene on chromosome 16. Genome-wide association studies consistently identify it as one of the strongest common genetic determinants of circulating high-density lipoprotein cholesterol (HDL-C) concentrations. Additionally, researchers have investigated this variant for subtle, complex associations with age-related macular degeneration (AMD) risk and metabolic health.
What each genotype means
Typical baseline HDL cholesterol
Carriers of the CC genotype typically exhibit lower baseline high-density lipoprotein cholesterol (HDL-C) levels compared to those carrying the alternate allele. Large genome-wide association studies link this background genotype with standard population lipid parameters and standard baseline risk for age-related macular degeneration. Emerging evidence suggests individuals with this genotype may also show a modest or attenuated HDL-C response to certain intensive lifestyle interventions.
Carried by roughly 35% to 50% of individuals across European, Admixed American, and South Asian populations, and up to 70% in East Asian populations.
Moderately higher HDL cholesterol
Carrying one copy of the A allele is statistically associated with moderately increased circulating HDL-C concentrations relative to the CC genotype. Published findings indicate each copy of the allele correlates with lower cholesteryl ester transfer protein activity and slightly modified susceptibilities to age-related macular degeneration in some ancestries. These statistical associations reflect broad population tendencies rather than individual cardiovascular or ocular diagnoses.
Carried by approximately 40% to 50% of individuals in European and South Asian cohorts, and roughly 25% to 30% in East Asian groups.
Elevated HDL cholesterol levels
Homozygosity for the A allele is associated with the highest statistical elevation in baseline HDL-C levels observed for this locus. Observational research also notes possible slight alterations in age-related macular degeneration susceptibility, though clinical relevance remains limited without broader lipid context. Because genetic associations interact heavily with diet, physical activity, and medication, clinical laboratory lipid testing remains essential for evaluating vascular health.
Found in about 9% to 15% of European and South Asian individuals, and fewer than 5% of individuals of East Asian ancestry.
Genomic Location and Variant Biology
The single nucleotide polymorphism rs3764261 is situated on chromosome 16q13 within the CETP gene locus. Specifically positioned upstream in an intronic regulatory region, it involves a single base substitution between cytosine (C) and adenine (A). Because it does not alter the protein coding sequence directly, rs3764261 acts primarily as an expression quantitative trait locus or tagging variant that modulates CETP gene expression. Cholesteryl ester transfer protein plays a vital role in lipid metabolism by facilitating the neutral lipid exchange of cholesteryl esters from protective HDL particles to atherogenic lipoproteins, such as very-low-density lipoproteins (VLDL) and low-density lipoproteins (LDL). Reduced expression or activity of CETP typically leads to delayed clearance of HDL particles, which in turn causes circulating HDL-C levels to rise in the bloodstream.
Impact on HDL Cholesterol and Lipid Traits
Large-scale genome-wide association studies (GWAS) have repeatedly confirmed that rs3764261 exhibits one of the strongest known common genetic signals affecting lipid biology. In population cohorts, carrying the minor A allele correlates in an additive fashion with reduced CETP activity and significantly elevated HDL-C levels, typically around 3 to 4 mg/dL per allele copy. Conversely, the major C allele is associated with lower average HDL-C levels. While higher HDL-C was historically assumed to automatically reduce cardiovascular risk, modern Mendelian randomization analyses reveal that genetically raised HDL-C driven by CETP variants does not straightforwardly guarantee cardioprotection. Instead, the variant reflects complex shifts in lipid remodeling, reverse cholesterol transport, and lipoprotein composition across tissues.
Association with Age-Related Macular Degeneration
Beyond circulating lipid panels, epidemiological research connects rs3764261 to susceptibility to age-related macular degeneration (AMD), a progressive condition affecting the central retina. Retinal pigment epithelial cells depend heavily on local lipid transport and homeostasis, as lipid-rich debris accumulates beneath the retina to form drusen. Meta-analyses and cohort studies have observed altered risks of AMD among carriers of rs3764261 alleles, often interacting with other major susceptibility loci such as CFH (complement factor H). However, published findings display notable population heterogeneity: several studies report that the HDL-raising A allele increases AMD risk, whereas other smaller regional studies observed divergent or protective effects. Because of these mixed directions and reliance on population-specific modifier genes, the clinical evidence linking this variant directly to AMD remains classified as limited and non-diagnostic.
Gene-Environment and Lifestyle Interactions
Genetics provides only a baseline tendency, and observational trials demonstrate that environmental factors can modify the influence of rs3764261. Clinical studies examining lifestyle modifications in young adults found that weight gain prevention programs could blunt or offset the HDL-lowering tendency associated with the CC genotype. Similarly, nutritional investigations, including data from large biobanks, show that dietary patterns such as vegetarian diets can interact with rs3764261 genotypes to shift circulating lipid concentrations. These interactions underscore that inherited CETP variations do not lock an individual into fixed blood lipid values. Dietary habits, physical exercise, body composition, and systemic metabolic health continuously interact with baseline genetic architecture to shape overall lipid profiles.
Clinical Utility and Practical Interpretation
Direct-to-consumer genetic reports often display rs3764261, but this variant is not a diagnostic marker for cardiovascular disease or retinal disorders. Possessing an allele associated with lower HDL-C does not equate to heart disease, nor does carrying an allele linked to elevated HDL-C guarantee cardiovascular immunity or eye pathology. Standard biochemical blood tests (such as standard lipid panels) and comprehensive eye exams by optometrists or ophthalmologists provide direct, actionable insight into health status that genetic risk estimates cannot match. Furthermore, individuals considering pharmacotherapy or participating in clinical discussions regarding lipid-lowering agents should rely on professional medical evaluations rather than single nucleotide polymorphism tests.
How common is this variant?
The rs3764261 variant is common across world populations, with the minor A allele occurring at frequencies between 0.30 and 0.45 in European and American cohorts, but generally observed at lower frequencies (approximately 0.15 to 0.20) in East Asian populations.
Frequently asked questions
Does having the rs3764261 CC genotype mean I have low HDL cholesterol?
Not necessarily. While the CC genotype is statistically linked to lower average HDL cholesterol in population studies, single variants explain only a fraction of overall lipid levels. Physical activity, diet, alcohol intake, and overall metabolic health play substantial roles in determining your actual HDL cholesterol.
Can rs3764261 predict whether I will develop macular degeneration?
No, rs3764261 cannot diagnose or predict age-related macular degeneration (AMD). Although researchers have detected modest statistical correlations in some population-wide studies, AMD is an intricate condition influenced by age, smoking status, systemic inflammation, and primary genetic loci like CFH and ARMS2.
Does genetically high HDL cholesterol protect against heart disease?
Not automatically. Modern genetic studies examining variants in the CETP gene have revealed that genetically increased HDL cholesterol does not necessarily translate into a reduced risk of heart attacks. Particle functionality and the balance of atherogenic particles like LDL and apoB are much stronger predictors of cardiovascular health.
Should I change my diet or medications based on my rs3764261 result?
No, you should not alter prescription medications or adopt restrictive diets based solely on this genetic marker. Medical decisions regarding lipid management or eye health should always be based on standard clinical tests, comprehensive eye examinations, and guidance from a qualified physician.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3764261?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CETP
CETP promoter variant associated with preserved cognitive function, elevated HDL levels, and exceptional longevity across European cohorts.
The B2 (A) allele of the TaqIB polymorphism is associated with lower CETP activity and significantly higher HDL-cholesterol levels.
The missense variant p.Ile422Val (I405V) in CETP is associated with reduced cholesteryl ester transfer protein activity, leading to elevated HDL-C levels and modest protection against coronary artery disease.
The I405V variant in CETP is associated with altered HDL cholesterol levels and cardiovascular risk profiles.
Well-established regulatory intronic polymorphism modulating cholesteryl ester transfer protein activity and circulating HDL cholesterol levels.
Known as the CETP TaqIB polymorphism, this intron variant is linked to reduced CETP activity, higher circulating HDL-C, and altered cardiovascular risk profile.